Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptides | 19 | 2016 | 320 | 4.750 |
Why?
|
| Nanotechnology | 14 | 2010 | 153 | 2.620 |
Why?
|
| Nanotubes, Peptide | 6 | 2010 | 6 | 1.970 |
Why?
|
| Ferric Compounds | 4 | 2022 | 51 | 1.620 |
Why?
|
| Crystallization | 12 | 2010 | 86 | 1.550 |
Why?
|
| Biomimetic Materials | 6 | 2010 | 23 | 1.490 |
Why?
|
| Nanoparticles | 7 | 2016 | 318 | 1.440 |
Why?
|
| Nanotubes | 5 | 2008 | 18 | 1.410 |
Why?
|
| Metal Nanoparticles | 5 | 2019 | 183 | 1.310 |
Why?
|
| Gold | 8 | 2010 | 136 | 1.150 |
Why?
|
| Lead | 3 | 2015 | 93 | 1.150 |
Why?
|
| Nanostructures | 5 | 2014 | 134 | 1.080 |
Why?
|
| Biosensing Techniques | 4 | 2010 | 86 | 1.070 |
Why?
|
| Transducers | 3 | 2009 | 12 | 1.050 |
Why?
|
| Immunoglobulin G | 4 | 2008 | 237 | 1.010 |
Why?
|
| Selenium Compounds | 2 | 2015 | 11 | 0.890 |
Why?
|
| Hyperthermia, Induced | 1 | 2022 | 17 | 0.870 |
Why?
|
| Zinc Oxide | 3 | 2011 | 16 | 0.800 |
Why?
|
| Semiconductors | 3 | 2010 | 10 | 0.750 |
Why?
|
| Microscopy, Atomic Force | 7 | 2015 | 60 | 0.710 |
Why?
|
| Silicon | 2 | 2009 | 17 | 0.690 |
Why?
|
| Nanowires | 2 | 2010 | 6 | 0.670 |
Why?
|
| Immunoassay | 2 | 2009 | 61 | 0.670 |
Why?
|
| Proteins | 2 | 2012 | 369 | 0.630 |
Why?
|
| Sulfides | 2 | 2010 | 62 | 0.610 |
Why?
|
| Viruses | 2 | 2008 | 36 | 0.600 |
Why?
|
| Surface Properties | 7 | 2014 | 130 | 0.590 |
Why?
|
| Dextrans | 1 | 2016 | 21 | 0.570 |
Why?
|
| Collagen | 4 | 2015 | 172 | 0.570 |
Why?
|
| Drug Carriers | 1 | 2016 | 125 | 0.530 |
Why?
|
| Water | 3 | 2014 | 296 | 0.530 |
Why?
|
| Antibodies | 2 | 2007 | 141 | 0.530 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 213 | 0.530 |
Why?
|
| Palladium | 2 | 2016 | 27 | 0.510 |
Why?
|
| Bacteriophage M13 | 1 | 2014 | 3 | 0.500 |
Why?
|
| Quantum Dots | 1 | 2015 | 30 | 0.500 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 10 | 0.500 |
Why?
|
| Biocatalysis | 1 | 2014 | 28 | 0.500 |
Why?
|
| Amino Acid Sequence | 7 | 2016 | 1180 | 0.480 |
Why?
|
| Biomimetics | 2 | 2012 | 10 | 0.470 |
Why?
|
| Temperature | 4 | 2008 | 286 | 0.440 |
Why?
|
| Energy Transfer | 1 | 2012 | 36 | 0.430 |
Why?
|
| Phenylalanine | 1 | 2012 | 25 | 0.430 |
Why?
|
| Peptide Fragments | 2 | 2016 | 308 | 0.430 |
Why?
|
| Capsules | 1 | 2012 | 25 | 0.410 |
Why?
|
| Silver | 2 | 2010 | 54 | 0.400 |
Why?
|
| Urease | 2 | 2009 | 15 | 0.400 |
Why?
|
| Osteosarcoma | 2 | 2022 | 26 | 0.390 |
Why?
|
| Escherichia coli | 2 | 2014 | 453 | 0.380 |
Why?
|
| Bone Neoplasms | 2 | 2022 | 45 | 0.380 |
Why?
|
| Mollusca | 1 | 2010 | 14 | 0.370 |
Why?
|
| Organometallic Compounds | 2 | 2014 | 73 | 0.350 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 76 | 0.350 |
Why?
|
| Motion | 2 | 2022 | 27 | 0.350 |
Why?
|
| Cell Separation | 1 | 2009 | 93 | 0.350 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2015 | 146 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 36 | 0.340 |
Why?
|
| Oligopeptides | 2 | 2014 | 102 | 0.340 |
Why?
|
| Calmodulin | 1 | 2009 | 46 | 0.340 |
Why?
|
| Microbial Viability | 1 | 2009 | 37 | 0.340 |
Why?
|
| Titanium | 2 | 2015 | 36 | 0.340 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 68 | 0.340 |
Why?
|
| Histidine | 3 | 2003 | 42 | 0.330 |
Why?
|
| Particle Size | 5 | 2014 | 215 | 0.330 |
Why?
|
| Molecular Conformation | 4 | 2010 | 152 | 0.330 |
Why?
|
| Riluzole | 2 | 2019 | 3 | 0.320 |
Why?
|
| Copper | 2 | 2012 | 105 | 0.320 |
Why?
|
| Materials Testing | 4 | 2010 | 69 | 0.320 |
Why?
|
| Microscopy, Scanning Probe | 1 | 2007 | 2 | 0.310 |
Why?
|
| Aniline Compounds | 1 | 2008 | 23 | 0.310 |
Why?
|
| Electric Capacitance | 1 | 2007 | 7 | 0.310 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2005 | 20 | 0.310 |
Why?
|
| Pyrroles | 1 | 2008 | 55 | 0.310 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 25 | 0.300 |
Why?
|
| Antigen-Antibody Complex | 1 | 2007 | 19 | 0.300 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 2231 | 0.300 |
Why?
|
| Biopolymers | 1 | 2007 | 18 | 0.300 |
Why?
|
| Gallium | 1 | 2007 | 2 | 0.300 |
Why?
|
| Minerals | 1 | 2007 | 47 | 0.290 |
Why?
|
| Catalysis | 4 | 2016 | 179 | 0.290 |
Why?
|
| Polymers | 1 | 2008 | 121 | 0.290 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 312 | 0.270 |
Why?
|
| Zinc Compounds | 1 | 2005 | 12 | 0.270 |
Why?
|
| Zinc Fingers | 1 | 2005 | 26 | 0.270 |
Why?
|
| Enzymes, Immobilized | 1 | 2005 | 14 | 0.270 |
Why?
|
| Antigens | 1 | 2005 | 56 | 0.260 |
Why?
|
| Antibodies, Immobilized | 3 | 2009 | 6 | 0.250 |
Why?
|
| Protein Folding | 1 | 2005 | 127 | 0.250 |
Why?
|
| Macromolecular Substances | 3 | 2010 | 96 | 0.240 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2016 | 11 | 0.240 |
Why?
|
| alpha-Cyclodextrins | 1 | 2003 | 1 | 0.230 |
Why?
|
| Cyclodextrins | 1 | 2003 | 10 | 0.230 |
Why?
|
| Azo Compounds | 1 | 2003 | 20 | 0.230 |
Why?
|
| Macrocyclic Compounds | 1 | 2003 | 12 | 0.230 |
Why?
|
| RNA, Small Interfering | 2 | 2022 | 409 | 0.230 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2007 | 364 | 0.230 |
Why?
|
| Nanotubes, Carbon | 1 | 2004 | 79 | 0.220 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1502 | 0.220 |
Why?
|
| Protein Conformation | 4 | 2015 | 389 | 0.220 |
Why?
|
| Sulfhydryl Compounds | 2 | 2016 | 47 | 0.190 |
Why?
|
| Animals | 9 | 2022 | 15081 | 0.190 |
Why?
|
| Mice | 6 | 2022 | 5913 | 0.180 |
Why?
|
| Electrodes | 2 | 2009 | 45 | 0.170 |
Why?
|
| Solutions | 2 | 2010 | 62 | 0.170 |
Why?
|
| Mutation | 2 | 2015 | 1095 | 0.150 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 1568 | 0.150 |
Why?
|
| Humans | 10 | 2022 | 37093 | 0.140 |
Why?
|
| Diazonium Compounds | 1 | 2016 | 1 | 0.140 |
Why?
|
| Enzymes | 1 | 2016 | 32 | 0.140 |
Why?
|
| Photochemical Processes | 1 | 2015 | 17 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2016 | 44 | 0.130 |
Why?
|
| Catalytic Domain | 1 | 2016 | 109 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 112 | 0.130 |
Why?
|
| Protein Binding | 2 | 2009 | 972 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2016 | 103 | 0.130 |
Why?
|
| Molecular Mimicry | 1 | 2015 | 16 | 0.130 |
Why?
|
| Graphite | 1 | 2016 | 51 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 295 | 0.130 |
Why?
|
| Friction | 1 | 2014 | 3 | 0.130 |
Why?
|
| Surface Tension | 1 | 2014 | 12 | 0.130 |
Why?
|
| Anisotropy | 1 | 2014 | 27 | 0.130 |
Why?
|
| Rotation | 1 | 2014 | 24 | 0.130 |
Why?
|
| Porosity | 1 | 2014 | 32 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 133 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2009 | 808 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 162 | 0.120 |
Why?
|
| Binding Sites | 2 | 2009 | 651 | 0.120 |
Why?
|
| Carbon | 1 | 2015 | 105 | 0.120 |
Why?
|
| Hydrolysis | 1 | 2014 | 99 | 0.120 |
Why?
|
| Equipment Design | 1 | 2014 | 124 | 0.120 |
Why?
|
| Elasticity | 1 | 2014 | 38 | 0.120 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 21 | 0.120 |
Why?
|
| Micelles | 1 | 2014 | 32 | 0.120 |
Why?
|
| Cell Size | 1 | 2014 | 44 | 0.120 |
Why?
|
| Herbal Medicine | 1 | 2014 | 8 | 0.120 |
Why?
|
| Amides | 1 | 2014 | 68 | 0.120 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2003 | 98 | 0.110 |
Why?
|
| Ultraviolet Rays | 2 | 2004 | 117 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 179 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2014 | 216 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2014 | 107 | 0.110 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 209 | 0.110 |
Why?
|
| Microtechnology | 1 | 2012 | 5 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 219 | 0.110 |
Why?
|
| Dipeptides | 1 | 2012 | 32 | 0.110 |
Why?
|
| Biological Products | 1 | 2014 | 71 | 0.110 |
Why?
|
| Oils | 1 | 2012 | 6 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 235 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2014 | 381 | 0.100 |
Why?
|
| Peptide Library | 1 | 2011 | 25 | 0.100 |
Why?
|
| Streptavidin | 1 | 2010 | 6 | 0.100 |
Why?
|
| Biotin | 1 | 2010 | 24 | 0.090 |
Why?
|
| Alkanesulfonic Acids | 1 | 2010 | 8 | 0.090 |
Why?
|
| X-Ray Diffraction | 1 | 2010 | 57 | 0.090 |
Why?
|
| Morpholines | 1 | 2010 | 69 | 0.090 |
Why?
|
| Macrophages | 1 | 2014 | 439 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 807 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 61 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2009 | 212 | 0.080 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 109 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 803 | 0.080 |
Why?
|
| Electric Conductivity | 1 | 2008 | 51 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2007 | 23 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 562 | 0.080 |
Why?
|
| Platinum | 1 | 2007 | 19 | 0.080 |
Why?
|
| Capsid | 1 | 2007 | 54 | 0.070 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2007 | 19 | 0.070 |
Why?
|
| Adsorption | 1 | 2007 | 68 | 0.070 |
Why?
|
| Capsid Proteins | 1 | 2007 | 67 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 208 | 0.070 |
Why?
|
| Bacteria | 1 | 2010 | 255 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2007 | 62 | 0.070 |
Why?
|
| Dimerization | 1 | 2007 | 112 | 0.070 |
Why?
|
| Ligands | 1 | 2007 | 349 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2007 | 207 | 0.070 |
Why?
|
| Lipase | 1 | 2005 | 18 | 0.070 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 20 | 0.070 |
Why?
|
| Candida | 1 | 2005 | 40 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2022 | 1198 | 0.060 |
Why?
|
| Female | 3 | 2015 | 20969 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 208 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 444 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2005 | 174 | 0.060 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2004 | 68 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 142 | 0.060 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2003 | 37 | 0.060 |
Why?
|
| Kinetics | 1 | 2005 | 708 | 0.060 |
Why?
|
| Ethers, Cyclic | 1 | 2003 | 5 | 0.060 |
Why?
|
| Ions | 1 | 2003 | 61 | 0.060 |
Why?
|
| Phthalic Acids | 1 | 2003 | 13 | 0.060 |
Why?
|
| Photochemistry | 1 | 2003 | 63 | 0.060 |
Why?
|
| Crystallography | 1 | 2003 | 7 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 58 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 132 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 60 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 77 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 76 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 337 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 259 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2019 | 326 | 0.040 |
Why?
|
| Cell Survival | 1 | 2019 | 864 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2015 | 4 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 67 | 0.030 |
Why?
|
| Hydrogen | 1 | 2016 | 47 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2015 | 51 | 0.030 |
Why?
|
| Biomass | 1 | 2015 | 54 | 0.030 |
Why?
|
| Light | 1 | 2015 | 187 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 431 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 689 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 935 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1518 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2379 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 6741 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 10129 | 0.010 |
Why?
|
| Male | 1 | 2019 | 20025 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 11712 | 0.010 |
Why?
|